Parkwood LLC Acquires 7,225 Shares of CVS Health Co. (NYSE:CVS)

Parkwood LLC boosted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 3.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 199,277 shares of the pharmacy operator's stock after buying an additional 7,225 shares during the period. Parkwood LLC's holdings in CVS Health were worth $8,946,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in CVS. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health in the 4th quarter valued at about $28,000. Hopwood Financial Services Inc. acquired a new position in CVS Health during the 4th quarter worth approximately $29,000. Financial Perspectives Inc lifted its position in CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after acquiring an additional 466 shares in the last quarter. Compass Planning Associates Inc acquired a new position in CVS Health during the 4th quarter worth approximately $37,000. Finally, MidAtlantic Capital Management Inc. lifted its position in CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after acquiring an additional 437 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Edward Jones upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. JPMorgan Chase & Co. boosted their price objective on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Argus set a $77.00 price target on CVS Health in a research report on Tuesday, February 18th. Finally, Royal Bank of Canada boosted their price target on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $74.94.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction dated Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of the company's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.22% of the company's stock.

CVS Health Trading Up 0.5%

Shares of CVS Health stock traded up $0.32 on Monday, reaching $62.85. 3,262,945 shares of the company were exchanged, compared to its average volume of 11,411,575. The stock has a fifty day moving average price of $66.57 and a 200-day moving average price of $59.24. The firm has a market capitalization of $79.51 billion, a price-to-earnings ratio of 17.21, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.31 earnings per share. On average, analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.23%. The ex-dividend date was Tuesday, April 22nd. CVS Health's payout ratio is 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.